FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/072985 [Registered on: 27/08/2024] Trial Registered Prospectively
Last Modified On: 24/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia
Process of Care Changes 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Evaluating the effectiveness of ultrasound guided pain relief methods for knee replacement surgeries 
Scientific Title of Study   To study the analgesic effectiveness of anterior femoral cutaneous nerve block in addition to proximal adductor canal block and local infiltration analgesia in patients undergoing unilateral primary total knee arthroplasty: A randomised controlled trial 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Debesh Bhoi 
Designation  Additional Professor 
Affiliation  AIIMS New Delhi 
Address  Room no 5020, 5th floor, Department of Anaesthesiology, Pain medicine and critical care, AIIMS New Delhi, South Delhi.

South
DELHI
110029
India 
Phone  7042129428  
Fax    
Email  drdebeshbhoi@aiims.edu  
 
Details of Contact Person
Scientific Query
 
Name  Debesh Bhoi 
Designation  Additional Professor 
Affiliation  AIIMS New Delhi 
Address  Room no 5020, 5th floor, Department of Anaesthesiology, Pain medicine and critical care, AIIMS New Delhi, South Delhi.

South
DELHI
110029
India 
Phone  7042129428  
Fax    
Email  drdebeshbhoi@aiims.edu  
 
Details of Contact Person
Public Query
 
Name  Sudhir Anand 
Designation  Junior Resident 
Affiliation  AIIMS New Delhi 
Address  Room no 5011, Anaesthesiology office, Department of Anaesthesiology, Pain medicine and critical care, 5th floor, Academic block, AIIMS New Delhi, South Delhi

South
DELHI
110029
India 
Phone  8825698405  
Fax    
Email  assasudhir@gmail.com  
 
Source of Monetary or Material Support  
Department of Anaesthesiology, Pain medicine and critical care, AIIMS New Delhi, Ansari nagar 110029 
 
Primary Sponsor  
Name  AIIMS New Delhi 
Address  Department of Anaesthesiology, Pain medicine and critical care, AIIMS New Delhi, Ansari nagar, New Delhi 110029 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Debesh Bhoi  All India Institute of Medical Sciences  Department of Anesthesiology, Pain medicine and Critical care, Room no 5020, Fifth floor , Academic block, All India Institute of Medical Sciences, Ansari nagar, New Delhi 110029
South
DELHI 
7042129428

drdebeshbhoi@aiims.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTE ETHICS COMMITTEE FOR POST GRADUATE RESEARCH ALL INDIA INSTITUTE OF MEDICAL SCIENCES  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M171||Unilateral primary osteoarthritisof knee,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Adductor canal block and local infiltration analgesia  Patients will receive adductor canal block and Local infiltration analgesia: Patient will made supine and operated limb will be little externally rotated. High frequency linear probe (6-13 MHz) probe will be placed medial side of thigh. Proximal part of adductor canal where the femoral artery is just medial to the sartorius muscle , identified with ultrasound. The needle (10 cm echogenic needle) is entered from lateral to medial, piercing the SM, 5 ml deposited around nerve to vastus medialis and then after piercing VAM, 15 mL LA( Ropivacaine 0.25%) will be injected between the femoral artery and the saphenous nerve for both groups. The injection of LA shapes into a hypoechoic sphere with a hyperechoic structure within represented by the saphenous nerve and posteromedial articular branch of nerve to vastus medialis.: After giving adductor canal block , With the probe in same position proximal adductor canal ,the branches of the anterior femoral cutaneous is found on the subcutaneous plane above the fascia lata covering the sartorius muscle. Anteriorly intermediate femoral cutaneous nerve is seen, needle is injected and 5 ml of 0.25% ropivacaine is injected around the nerve . Further on moving medially medial femoral cutaneous nerve is visualized and another 5 ml of 0.25% ropivacaine is injected. If the nerve is not visualized 10 ml LA will be deposited in superficial plane to sartorius muscle .(as per anatomy of the nerve).This procedure will take around five minutes 
Intervention  Anterior femoral cutaneous nerve block + Adductor canal block along with local infiltration analgesia  Patients will receive adductor canal block and Local infiltration analgesia: Patient will made supine and operated limb will be little externally rotated. High frequency linear probe (6-13 MHz) probe will be placed medial side of thigh. Proximal part of adductor canal where the femoral artery is just medial to the sartorius muscle , identified with ultrasound. The needle (10 cm echogenic needle) is entered from lateral to medial, piercing the SM, 5 ml deposited around nerve to vastus medialis and then after piercing VAM, 15 mL LA( Ropivacaine 0.25%) will be injected between the femoral artery and the saphenous nerve for both groups. The injection of LA shapes into a hypoechoic sphere with a hyperechoic structure within represented by the saphenous nerve and posteromedial articular branch of nerve to vastus medialis.: After giving adductor canal block , With the probe in same position proximal adductor canal ,the branches of the anterior femoral cutaneous is found on the subcutaneous plane above the fascia lata covering the sartorius muscle. Anteriorly intermediate femoral cutaneous nerve is seen, needle is injected and 5 ml of 0.25% ropivacaine is injected around the nerve . Further on moving medially medial femoral cutaneous nerve is visualized and another 5 ml of 0.25% ropivacaine is injected. If the nerve is not visualized 10 ml LA will be deposited in superficial plane to sartorius muscle .(as per anatomy of the nerve) At the end of surgery, in both the groups surgeons will performs local infiltration analgesia using 50 ml of 0.25% ropivacaine + 30 mg ketorolac + 0.3 mg epinephrine around the medial collateral ligament, anterior capsule, fat pad, medial and lateral meniscus remnants and the posterior capsule with care taken to avoid inadverdent peroneal nerve injection.This whole procedure will take around ten minutes  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1) ASA I+II+III
2) 18 TO 70 Years
3) Patients undergoing unilateral primary Total knee arthroplasty 
 
ExclusionCriteria 
Details  1.Patient refusal
2.Varus valgus deformity > 20 degree
3.Flexion deformity > 30 degree
4.BMI > 30 kg/sq.cm
5.Contraindication to neuraxial anaesthesia
6.Allergy to local anaesthetics, NSAIDS, Opioids
7.Chronic opioid use > 3 month duration
8.Previous knee surgery
9.Pregnant females at the time of recruitment
10.Progressive neurological deficit in femoral, obturator or sciatic nerve distribution.
11.Severe cardiac co-morbidities, hepatic or renal dysfunction, coagulopathy
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Cumulative postoperative analgesic consumption in 36 hours as IV morphine equivalents  36 hours 
 
Secondary Outcome  
Outcome  TimePoints 
1.Numeric rating scale of pain (0 minimum-10 worst pain) at various intervals
2.NRS at movement after mobilization at various time intervals
3.Time of first rescue analgesic
4.Quality of Recovery (QoR -15) at 24 hr and 48 hr
5.Timed up and go (TUG) Test scores
6.Patient satisfaction
7.Length of hospital stay
8.Sleep quality (no of times awakening because of Pain)
9.Observe any adverse effect (following LIA, ACB and AFCB -vascular puncture, motor blockade or Local analgesic systemic toxicity). 
1.0, 30 min, 1 hr,2 , 4 ,6 , 8, 12, 24 ,36 and 48 hours 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   04/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  04/09/2024 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Total knee arthroplasty (TKA) is commonly conducted surgery and about 2.5 lakh people undergo TKR in India every year. Failure to provide adequate analgesia may affect physical rehabilitation, which is important to improve joint range of motion and promote satisfactory results.Various different peripheral nerve blockade techniques such as sciatic nerve block, obturator nerve block which anaesthetize the posterior part of knee, femoral nerve block and adductor canal block taking care of the anteromedial aspect of knee and obturator nerve block have been described.Femoral nerve block caused motor blockade of the quadriceps femoris muscle so to overcome this motor sparing adductor canal block was given.In order to cover the posterior aspect of knee, infiltration between the popliteal artery and capsule of the knee (IPACK) was introduced and combination of ACB with IPACK was preferredThe advent of local infiltration anaesthesia which is given around the knee involving the medial and lateral remnants, posterior capsule found noninferior to IPACK.So, the standard block preferred for TKR is ACB+LIA. Though ACB+LIA is better it cannot cover the anterior or anteromedial skin incision of the TKR surgery as the dermatomal distribution of this area is supplied by Anterior cutaneous femoral nerve. So, we hypothesize that, additional Anterior femoral cutaneous block, along with proximal ACB and LIA, will empower analgesia and will reduce the opioid consumption and improves postoperative recovery.

 
Close